4-Methyl-2-(methylthio)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine

Catalog No. :
ACOMBG970
CAS No. :
1309981-17-6
Molecular Formula :
C12H19BN2O2S
Molecular Weight :
266.17

IUPAC Name:4-Methyl-2-(methylthio)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine

4-Methyl-2-(methylthio)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methyl-2-(methylthio)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
IUPAC Name4-Methyl-2-(methylthio)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
Molecular FormulaC12H19BN2O2S
Molecular Weight266.17
SMILESCC1(C)C(C)(C)OB(C2=CC(C)=NC(SC)=N2)O1
InChI KeyVGYAPBFQVPKFEE-UHFFFAOYSA-N
Synonym4-Methyl-2-(methylthio)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
CAS No.1309981-17-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOMBG970 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACMWBH467 route compound structure diagram
    ACMWBH46717119-73-2 In Stock
  4. Then
  5. ACOMBG970 route product structure diagram
    ACOMBG9701309981-17-6
Inquiry

2. ACOMBG970 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOMBG970 route product structure diagram
    ACOMBG9701309981-17-6
Inquiry

Comments (0)